Status:
UNKNOWN
Inflammation and Steatosis: the Role of Alpha-defensin
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Inflammation
Fatty Liver
Eligibility:
All Genders
15+ years
Brief Summary
The aim of this study is to examine the correlation between the severity of non-alcoholic steatohepatitis/non alcoholic fatty liver disease (NASH/NAFLD) in naïve and hepatitis C (HCV) positive patient...
Eligibility Criteria
Inclusion
- Fatty liver disease patients with liver biopsy
Exclusion
- None
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03358420
Start Date
December 1 2017
End Date
July 1 2018
Last Update
November 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hille Yaffe Medical Center
Hadera, Israel, 38100